140 related articles for article (PubMed ID: 11973173)
1. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP).
de Jonge J; Groenland TH; Metselaar HJ; IJzermans JN; van Vliet HH; Visser L; Tilanus HW
Anesth Analg; 2002 May; 94(5):1127-31, table of contents. PubMed ID: 11973173
[TBL] [Abstract][Full Text] [Related]
2. Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas).
Magner JJ; Crowley KJ; Boylan JF
J Cardiothorac Vasc Anesth; 2007 Jun; 21(3):410-3. PubMed ID: 17544896
[No Abstract] [Full Text] [Related]
3. A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during Orthotopic Liver Transplantation.
Freeman JW; Williamson LM; Llewelyn C; Fisher N; Allain JP; Bellamy M; Baglin TP; Klinc J; Ala FA; Smith N; Neuberger J; Wreghitt T
Vox Sang; 1998; 74 Suppl 1():225-9. PubMed ID: 9789533
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas).
Solheim BG; Bergan A; Brosstad F; Innes R; Svennevig JL
Anesth Analg; 2003 Apr; 96(4):1230-1231. PubMed ID: 12651690
[No Abstract] [Full Text] [Related]
5. Solvent/detergent-treated plasma: composition, efficacy, and safety.
Hellstern P
Curr Opin Hematol; 2004 Sep; 11(5):346-50. PubMed ID: 15666659
[TBL] [Abstract][Full Text] [Related]
6. Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.
Saadah NH; van der Meer PF; Brinkman HJM; de Korte D; Bontekoe IJ; Korsten HH; Middelburg RA; van der Bom JG; Schipperus MR
Transfusion; 2017 Oct; 57(10):2381-2389. PubMed ID: 28727139
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.
Williamson LM; Llewelyn CA; Fisher NC; Allain JP; Bellamy MC; Baglin TP; Freeman J; Klinck JR; Ala FA; Smith N; Neuberger J; Wreghitt TG
Transfusion; 1999; 39(11-12):1227-34. PubMed ID: 10604250
[TBL] [Abstract][Full Text] [Related]
8. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
[TBL] [Abstract][Full Text] [Related]
9. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.
Beck KH; Mortelmans Y; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():440-4. PubMed ID: 9422123
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of hyperfibrinolysis and thromboembolism in 195 primary liver transplantations transfused with solvent/detergent-treated plasma.
Haugaa H; Taraldsrud E; Nyrerød HC; Tønnessen TI; Foss A; Solheim BG
Clin Med Res; 2014 Sep; 12(1-2):27-32. PubMed ID: 24415744
[TBL] [Abstract][Full Text] [Related]
11. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma.
Horowitz B; Lazo A; Grossberg H; Page G; Lippin A; Swan G
Vox Sang; 1998; 74 Suppl 1():203-6. PubMed ID: 9789529
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of prion-filtered red cells suspended in pathogen-inactivated plasma (MB treated or solvent-detergent treated) for neonatal exchange transfusion.
Hornsey VS; Casey C; McColl K; Young H; Drummond O; McMillan L; Morrison A; Prowse CV
Vox Sang; 2011 Jul; 101(1):28-34. PubMed ID: 21175669
[TBL] [Abstract][Full Text] [Related]
13. Solvent/detergent-treated plasma: a tale of 30 years of experience.
Liumbruno GM; Marano G; Grazzini G; Capuzzo E; Franchini M
Expert Rev Hematol; 2015 Jun; 8(3):367-74. PubMed ID: 25695198
[TBL] [Abstract][Full Text] [Related]
14. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111
[TBL] [Abstract][Full Text] [Related]
15. Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity.
Mast AE; Stadanlick JE; Lockett JM; Dietzen DJ
Blood; 1999 Dec; 94(11):3922-7. PubMed ID: 10572109
[TBL] [Abstract][Full Text] [Related]
16. Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.
Biesert L; Suhartono H
Vox Sang; 1998; 74 Suppl 1():207-12. PubMed ID: 9789530
[TBL] [Abstract][Full Text] [Related]
17. Mediators of fibrinolysis in orthotopic liver transplantation.
Cheema SP; Webster NR; Dunn F; Bellamy MC
Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
[TBL] [Abstract][Full Text] [Related]
18. Virus safety of pooled fresh-frozen plasma inactivated by solvent/detergent treatment.
Prince AM; Horowitz B
Beitr Infusionsther; 1993; 31():21-4. PubMed ID: 7693256
[No Abstract] [Full Text] [Related]
19. Incidence and clinical significance of hyperfibrinolysis during living donor liver transplantation.
Kim EH; Ko JS; Gwak MS; Lee SK; Kim GS
Blood Coagul Fibrinolysis; 2018 Apr; 29(3):322-326. PubMed ID: 29621008
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma.
Beeck H; Hellstern P
Vox Sang; 1998; 74 Suppl 1():219-23. PubMed ID: 9789532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
